InflaRx Announces Vilobelimab Trial in Pyoderma Gangrenosum Selected for Late-Breaker Oral Presentation at 2022 AAD Annual Meeting

Written by Andreas Villaester on 8th March 2022. Posted in Client News.

• Previous
• Next